Literature DB >> 10881898

Oral statins and increased bone-mineral density in postmenopausal women.

C J Edwards, D J Hart, T D Spector.   

Abstract

Experimental evidence suggests that the cholesterol-lowering drugs statins increase bone formation. We report a significant increase of bone-mineral density associated with taking statins in postmenopausal women.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10881898     DOI： 10.1016/s0140-6736(00)02408-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  69 in total

Review 1.  HMG CoA reductase inhibitors and the skeleton: a comprehensive review.

Authors:  D C Bauer
Journal:  Osteoporos Int       Date:  2003-05-08       Impact factor: 4.507

2.  Short-term reduction in bone markers with high-dose simvastatin.

Authors:  Robert S Rosenson; Christine C Tangney; Craig B Langman; Thomas S Parker; Daniel M Levine; Bruce R Gordon
Journal:  Osteoporos Int       Date:  2005-08-09       Impact factor: 4.507

3.  Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations.

Authors:  G E Gutierrez; D Lalka; I R Garrett; G Rossini; G R Mundy
Journal:  Osteoporos Int       Date:  2006-05-03       Impact factor: 4.507

4.  Effects of Artemisia Princeps Supplementation on Bone Metabolism in Ovariectomized Rats.

Authors:  H-J Cho; J-W Kim; S-Y Ju; Y-K Park
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 5.  Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

Authors:  Christos Hatzigeorgiou; Jeffrey L Jackson
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

6.  Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.

Authors:  Canan Tikiz; Hakan Tikiz; Fatma Taneli; Gül Gümüşer; Ciğdem Tüzün
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

7.  Association between dietary fat intake and bone mineral density in Korean adults: data from Korea National Health and Nutrition Examination Survey IV (2008 ∼ 2009).

Authors:  Y-M Kwon; G W Kim; H W Yim; Y J Paek; K-S Lee
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

Review 8.  Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases.

Authors:  Paolo Calabro; Edward T H Yeh
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

9.  The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells.

Authors:  Ki Hyun Baek; Won Young Lee; Ki Won Oh; Hyun Jung Tae; Jung Min Lee; En Jung Lee; Je Ho Han; Moo Il Kang; Bong Yun Cha; Kwang Woo Lee; Ho Young Son; Sung Koo Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

10.  Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial.

Authors:  Lars Rejnmark; Peter Vestergaard; Lene Heickendorff; Leif Mosekilde
Journal:  Int J Endocrinol       Date:  2009-07-21       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.